French Pharmaceuticals & Biotech Leverage Leaders

Sanofi

Market Cap: €91.5b

Engages in the research, development, manufacture, and marketing of therapeutic solutions.

Ipsen

Market Cap: €12.7b

A biopharmaceutical company, develops and commercializes medicines in the areas of oncology, rare disease, and neuroscience worldwide.

Virbac

Market Cap: €2.9b

Manufactures and sells a range of products and services for companion and farm animals in Europe, North America, Latin America, East Asia, India, Africa, the Middle East, and the Pacific.

ABIVAX Société Anonyme

Market Cap: €7.4b

A clinical-stage biotechnology company, focuses on developing therapeutics that harness the body’s natural regulatory mechanisms to stabilize the immune response in patients with chronic inflammatory diseases.